METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
HONG KONG and NEW YORK, June 30, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a leading AI-driven drug delivery innovation company, today announced it has entered into an exclusive global licensing agreement with Boulevard Bio ("Boulevard"), a U.S. biotechnology company backed by Deerfield Management, granting Boulevard worldwide development, manufacturing, and commercialization rights...
WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
WUXI, China, June 30, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi — Drug Substance Facility 2 (MFG2) and Drug Product Facility 1 (DP1) — together with its Drug Product Packaging Center (DPPC), have received GMP certification from Brazil's Agência Nacional...
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
SAN DIEGO, June 30, 2026 /PRNewswire/ -- At BIO 2026, EirGenix presented its comprehensive HER2-positive breast cancer biosimilar portfolio and highlighted its integrated one-stop contract development and manufacturing organization (CDMO) service platform. The company actively pursued U.S. market opportunities through business matchmaking and global partnership discussions. While antibody-drug conjugates, other oncology and immunology biologics, and biosimilars continue to...
New Echelon Insights Survey Commissioned by Rockefeller Foundation: Most Americans Back Foreign Aid a Year After USAID’s End
A majority (54%) across the political spectrum remains favorable toward foreign aid a year after USAID's dismantlement, and 8 in 10 say the path forward is to reform and strengthen foreign aid — not eliminate it. Seven in ten Americans — including half of those who primarily support Trump over the Republican Party — would support spending...
International Alcohol Control Online Symposium Held: Focusing on Global and Low- and Middle-Income Country Response Strategies
MACAU, June 30, 2026 /PRNewswire/ -- The International Alcohol Control Online Symposium, organized by experts from the World Health Organization (WHO), the International Agency for Research on Cancer (IARC) Biobank and Cohort Building Network (BCNet), and other institutions, has reaffirmed that alcohol is a Group 1 carcinogen. Any level of consumption increases health risks, and it is generally...
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, and Eli Lilly and Company (NYSE: LLY) today jointly announced that they have entered into a...
Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence
Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery BOSTON, June 30, 2026 /PRNewswire/ -- Xellar Biosystems today announced the closing of $50 million in Series A and A+ financing to advance its vision of building the world's leading 3D Bio Intelligence platform. The financing will support the expansion of...
Anta Group’s HEMIN Foundation Releases 2025 Annual Report; RMB 2 Billion Donation-Funded Public Tertiary Hospital to Open Within the Year
JINJIANG, China, June 30, 2026 /PRNewswire/ -- Today, Anta Group's HEMIN Foundation released its 2025 Annual Report. Since its establishment in 2021 with a RMB 10 billion endowment from the founding family of ANTA Group, the Foundation has focused on three key areas: healthcare, sports and education, and community care. As of the end of 2025, cumulative donations...
Ozelle to Debut O-Cyte 1 at ADLM 2026, Bringing Speed to AI-Powered Morphology Intelligence
The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis ANAHEIM, Calif. and FRANKFURT, Germany, June 30, 2026 /PRNewswire/ -- Ozelle will unveil O-Cyte 1, its newest automated hematology analyzer, at ADLM 2026 in California. Making its global debut at one of the leading international events for...
BRAHMA AI, Hakuhodo Technologies Partner to Scale High-Fidelity Digital Humans Across Japan and APAC
LONDON and TOKYO, June 29, 2026 /PRNewswire/ -- BRAHMA AI and Hakuhodo Technologies today announced a strategic partnership to develop, commercialize, and deploy high-fidelity digital humans at enterprise scale across Japan and the Asia-Pacific (APAC) region. Digital Human (ATMAN) of Hibari Misora, featured in the BS Nippon TV...
